You may qualify for this study if you:
To find out if you qualify, please click the button below. If you would like to speak to a study nurse instead, please call 1-877-847-9076.
Glaucoma is a group of eye conditions resulting in optic nerve damage, which may cause loss of vision. Ocular hypertension is when the pressure inside the eye (intraocular pressure or IOP) is higher than normal. Ocular hypertension can develop into glaucoma.
This study will research a prescription, branded medication that is approved for use in eye drops, and has been used by millions of patients. It is being tested in an investigational dropless delivery system. There is no placebo in this research study—all participants will receive treatment in both eyes.
Study participation is 20 months (25 visits to the research clinic and 6 phone calls).
During the study, you will receive study-related care and investigational medication at no cost.
Study-related doctor visits will provide you with thorough eye exams and check that the study medication is working. Your study medication will be provided throughout the research study. Plus, you may also receive additional compensation for your time and necessary travel to study visits.
Your time is valuable, therefore we appreciate your interest in researching the future of glaucoma therapy.